Interesting that FDA didnt say that they refused to approve for severe/critical patients , 4 weeks of treatment ..
And VERY interesting we saving lives around the world , like patients in England coming off ECMO after 70 days , but only US FDA see no value of leronlimab , but a big value in remdesivir..
My only wish , they be investigated by people not related to BP , but I dont think we have anyone like that in USA anymore ..
How tragic this all is, as people dying..
Dr Woodcock , congratulation , your work in FDA is really great....:((
All IMO.